RETRACTED: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer

Table 3

The results of acute toxicity testing of NPs-SHP2.

Control	Death number	Death rate (%)	Survival (%)
NPs	0	0	100
NPs-SHP2	0	0	100
PBS	0	0	100